1. Home
  2. VABK vs CRBU Comparison

VABK vs CRBU Comparison

Compare VABK & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.50

Market Cap

207.9M

Sector

Finance

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.93

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
CRBU
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.9M
179.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VABK
CRBU
Price
$40.50
$1.93
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
4.3K
979.7K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.62%
N/A
EPS Growth
12.70
3.64
EPS
3.55
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
N/A
$10.93
P/E Ratio
$11.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.56
$0.71
52 Week High
$44.50
$3.53

Technical Indicators

Market Signals
Indicator
VABK
CRBU
Relative Strength Index (RSI) 62.06 52.39
Support Level $38.17 $1.70
Resistance Level $41.33 $2.06
Average True Range (ATR) 0.55 0.12
MACD 0.26 -0.00
Stochastic Oscillator 100.00 66.20

Price Performance

Historical Comparison
VABK
CRBU

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: